Slide

Innovations Inspired
by life

About Sparc

About Us

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics to improve standards of care for patients worldwide. At SPARC, our therapeutic focus is in the area of oncology, neurology and immunology, three critical fields that pose significant challenges in healthcare.

Therapeutic Focus

Oncology

We pioneer precision medicines and targeted delivery to overcome treatment resistance and achieve lasting remission.

Neurodegeneration

We explore new pathways to address the root causes of neurodegeneration, altering disease progression and enhancing patients' quality of life.

R&D Pipeline

Asset / Program

MoA

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Neurology

c-ABL
Inhibitor

Parkinson’s Disease
Lewy Body Dementia
Alzheimer’s Disease

Oncology

BCR-ABL
Inhibitor

Refractory CML

Anti-MUC-1 ADC

Multiple Tumors

Immunology

Selective
S1PR1 Agonist

Psoriasis
Atopic Dermatitis

Undisclosed

Alopecia Areata

R&D Pipeline

Phase 2

c-ABL Inhibitor for Parkinson’s Disease

Phase 2

c-ABL Inhibitor for Lewy Body Dementia

Preclinical

c-ABL Inhibitor for Alzheimer’s Disease

Phase 2

BCR-ABL Inhibitor for Refractory CML

Preclinical

Anti-MUC-1 ADC for Multiple Tumors

Phase 2

Selective S1PR1 Agonist for Psoriasis

Phase 2

Selective S1PR1 Agonist for Atopic Dermatitis

Phase 1

Undisclosed for Alopecia Areata
Copyright @ 2024. All Rights Reserved.
Follow Us :